{
     "PMID": "28398476",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171030",
     "LR": "20180125",
     "IS": "1460-2156 (Electronic) 0006-8950 (Linking)",
     "VI": "140",
     "IP": "5",
     "DP": "2017 May 1",
     "TI": "Glycation potentiates alpha-synuclein-associated neurodegeneration in synucleinopathies.",
     "PG": "1399-1419",
     "LID": "10.1093/brain/awx056 [doi]",
     "AB": "alpha-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several other neurodegenerative diseases known as synucleinopathies. The toxic properties of alpha-synuclein are conserved from yeast to man, but the precise underpinnings of the cellular pathologies associated are still elusive, complicating the development of effective therapeutic strategies. Combining molecular genetics with target-based approaches, we established that glycation, an unavoidable age-associated post-translational modification, enhanced alpha-synuclein toxicity in vitro and in vivo, in Drosophila and in mice. Glycation affected primarily the N-terminal region of alpha-synuclein, reducing membrane binding, impaired the clearance of alpha-synuclein, and promoted the accumulation of toxic oligomers that impaired neuronal synaptic transmission. Strikingly, using glycation inhibitors, we demonstrated that normal clearance of alpha-synuclein was re-established, aggregation was reduced, and motor phenotypes in Drosophila were alleviated. Altogether, our study demonstrates glycation constitutes a novel drug target that can be explored in synucleinopathies as well as in other neurodegenerative conditions.",
     "CI": [
          "(c) The Author (2017). Published by Oxford University Press on behalf of the",
          "Guarantors of Brain. All rights reserved. For Permissions, please email:",
          "journals.permissions@oup.com."
     ],
     "FAU": [
          "Vicente Miranda, Hugo",
          "Szego, Eva M",
          "Oliveira, Luis M A",
          "Breda, Carlo",
          "Darendelioglu, Ekrem",
          "de Oliveira, Rita M",
          "Ferreira, Diana G",
          "Gomes, Marcos A",
          "Rott, Ruth",
          "Oliveira, Marcia",
          "Munari, Francesca",
          "Enguita, Francisco J",
          "Simoes, Tania",
          "Rodrigues, Eva F",
          "Heinrich, Michael",
          "Martins, Ivo C",
          "Zamolo, Irina",
          "Riess, Olaf",
          "Cordeiro, Carlos",
          "Ponces-Freire, Ana",
          "Lashuel, Hilal A",
          "Santos, Nuno C",
          "Lopes, Luisa V",
          "Xiang, Wei",
          "Jovin, Thomas M",
          "Penque, Deborah",
          "Engelender, Simone",
          "Zweckstetter, Markus",
          "Klucken, Jochen",
          "Giorgini, Flaviano",
          "Quintas, Alexandre",
          "Outeiro, Tiago F"
     ],
     "AU": [
          "Vicente Miranda H",
          "Szego EM",
          "Oliveira LMA",
          "Breda C",
          "Darendelioglu E",
          "de Oliveira RM",
          "Ferreira DG",
          "Gomes MA",
          "Rott R",
          "Oliveira M",
          "Munari F",
          "Enguita FJ",
          "Simoes T",
          "Rodrigues EF",
          "Heinrich M",
          "Martins IC",
          "Zamolo I",
          "Riess O",
          "Cordeiro C",
          "Ponces-Freire A",
          "Lashuel HA",
          "Santos NC",
          "Lopes LV",
          "Xiang W",
          "Jovin TM",
          "Penque D",
          "Engelender S",
          "Zweckstetter M",
          "Klucken J",
          "Giorgini F",
          "Quintas A",
          "Outeiro TF"
     ],
     "AD": "CEDOC, Chronic Diseases Research Centre, NOVA Medical School | Faculdade de Ciencias Medicas, Universidade NOVA de Lisboa, Campo dos Martires da Patria, 130, 1169-056 Lisboa, Portugal. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration (BIN), University Medical Center Gottingen, Waldweg 33, 37073 Gottingen, Germany. Centro de Investigacao Interdisciplinar Egas Moniz, Instituto Superior de Ciencias da Saude Egas Moniz, 2829-511 Monte de Caparica, Caparica, Portugal. Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany. Department of Genetics, University of Leicester, Leicester LE1 7RH, UK. Department of Genetics, University of Leicester, Leicester LE1 7RH, UK. Bingol University, Science and Letters Faculty, Molecular Biology and Genetics Department, 12000, Bingol, Turkey. CEDOC, Chronic Diseases Research Centre, NOVA Medical School | Faculdade de Ciencias Medicas, Universidade NOVA de Lisboa, Campo dos Martires da Patria, 130, 1169-056 Lisboa, Portugal. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration (BIN), University Medical Center Gottingen, Waldweg 33, 37073 Gottingen, Germany. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany. German Center for Neurodegenerative Diseases (DZNE), 37077 Gottingen, Germany. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Laboratorio de Proteomica, Departamento de Genetica Humana, Instituto Nacional de Saude Dr. Ricardo Jorge, 1649-016 Lisboa, Portugal. Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration (BIN), University Medical Center Gottingen, Waldweg 33, 37073 Gottingen, Germany. Department of Molecular Neurology, University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Institute of Medical Genetics and Applied Genomics, University of Tuebingen, 72074 Tuebingen, Germany. Institute of Medical Genetics and Applied Genomics, University of Tuebingen, 72074 Tuebingen, Germany. Enzymology Group, Departamento de Quimica e Bioquimica, Centro de Quimica e Bioquimica, Faculdade de Ciencias da Universidade de Lisboa, Campo Grande, Edificio C8, 1749-016, Lisboa, Portugal. Enzymology Group, Departamento de Quimica e Bioquimica, Centro de Quimica e Bioquimica, Faculdade de Ciencias da Universidade de Lisboa, Campo Grande, Edificio C8, 1749-016, Lisboa, Portugal. Laboratory of Molecular and Chemical Biology of Neurodegeneration, Swiss Federal Institute of Technology Lausanne (EPFL), FSV-BMI AI 2137.1, Station 15, CH-1015 Lausanne, Switzerland. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. Institute for Biochemistry, Friedrich-Alexander-University Erlangen-Nurnberg (FAU), Erlangen, Germany. Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany. Laboratorio de Proteomica, Departamento de Genetica Humana, Instituto Nacional de Saude Dr. Ricardo Jorge, 1649-016 Lisboa, Portugal. Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel. Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany. German Center for Neurodegenerative Diseases (DZNE), 37077 Gottingen, Germany. Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, 37075 Gottingen, Germany. Department of Molecular Neurology, University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany. Department of Genetics, University of Leicester, Leicester LE1 7RH, UK. Centro de Investigacao Interdisciplinar Egas Moniz, Instituto Superior de Ciencias da Saude Egas Moniz, 2829-511 Monte de Caparica, Caparica, Portugal. CEDOC, Chronic Diseases Research Centre, NOVA Medical School | Faculdade de Ciencias Medicas, Universidade NOVA de Lisboa, Campo dos Martires da Patria, 130, 1169-056 Lisboa, Portugal. Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Center for Biostructural Imaging of Neurodegeneration (BIN), University Medical Center Gottingen, Waldweg 33, 37073 Gottingen, Germany. Max Plank Institute for Experimental Medicine, Goettingen, Germany.",
     "LA": [
          "eng"
     ],
     "GR": [
          "G-1203/Parkinson's UK/United Kingdom"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "England",
     "TA": "Brain",
     "JT": "Brain : a journal of neurology",
     "JID": "0372537",
     "RN": [
          "0 (Enzyme Inhibitors)",
          "0 (alpha-Synuclein)",
          "722KLD7415 (Pyruvaldehyde)"
     ],
     "SB": "AIM IM",
     "MH": [
          "Aging/metabolism",
          "Animals",
          "Cell Differentiation/drug effects",
          "Cell Survival/drug effects/physiology",
          "Cells, Cultured",
          "Disease Models, Animal",
          "Drosophila",
          "Enzyme Inhibitors/pharmacology",
          "Female",
          "Glycosylation/drug effects",
          "Hippocampus/drug effects/physiology",
          "Humans",
          "Induced Pluripotent Stem Cells/drug effects/physiology",
          "Male",
          "Mice",
          "Mice, Transgenic",
          "Neurodegenerative Diseases/*metabolism",
          "Protein Aggregation, Pathological/*metabolism",
          "Protein Processing, Post-Translational",
          "Pyruvaldehyde/pharmacology",
          "Rats",
          "Yeasts/drug effects/physiology",
          "alpha-Synuclein/drug effects/*metabolism/physiology/*toxicity"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Parkinson's disease",
          "alpha-synuclein",
          "glycation",
          "neurodegeneration"
     ],
     "EDAT": "2017/04/12 06:00",
     "MHDA": "2017/10/31 06:00",
     "CRDT": [
          "2017/04/12 06:00"
     ],
     "PHST": [
          "2016/06/29 00:00 [received]",
          "2017/01/20 00:00 [accepted]",
          "2017/04/12 06:00 [pubmed]",
          "2017/10/31 06:00 [medline]",
          "2017/04/12 06:00 [entrez]"
     ],
     "AID": [
          "3111637 [pii]",
          "10.1093/brain/awx056 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain. 2017 May 1;140(5):1399-1419. doi: 10.1093/brain/awx056.",
     "term": "hippocampus"
}